InsiderPulseNo transactions found.
No annual data found.
Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
Vaxart anticipates early 2027 primary efficacy readout while aiming for Q2 sentinel data release
Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript
Vaxart GAAP EPS of $0.02 in-line, revenue of $39.2M misses by $26.3M